Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 07.09.2026 2 BMJ 1 J Gen Virol 1 J Infect 3 J Infect Dis 3 JAMA 1 Lancet 1 MMWR Morb Mortal Wkly Rep 2 N Engl J Med 4 Pediatrics 1 PLoS Comput Biol 1 PLoS Med 4 PLoS One 2 Proc Natl Acad Sci U S A 1 Science 19 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. YANG YT
   Covid-19 vaccine study: scientific asylum should never have been necessary.
   BMJ. 2026;394:e100738.
   PubMed        
   
   
2. O'DOWD A
   UK childhood vaccination rates fall in babies but stabilise at age 5.
   BMJ. 2026;394:e100718.
   PubMed        
   
   

   
   J Gen Virol

3. HAYES JWP, Edwards JC, Valdez KR, Crossley S, et al
   Evaluation of the contribution of the minor envelope complex glycoprotein 3 ectodomain to the porcine reproductive and respiratory syndrome virus 1 neutralizing antibody response.
   J Gen Virol. 2026;107:002328.
   PubMed         Abstract available
   
   

   
   J Infect

4. WALKER JL, Ribeiro S, Litt D, Patel T, et al
   Antenatal pertussis vaccine effectiveness in England remains high post COVID-19.
   J Infect. 2026;93:106836.
   PubMed         Abstract available
   
   

   
   J Infect Dis

5. MILLER SL, Billings WZ, John M, Hemme H, et al
   Evaluation of Serum Antibodies as Correlates of Protection Against Norovirus Infection and Disease.
   J Infect Dis. 2026;234:220-228.
   PubMed         Abstract available
   
   
6. BAKER JM, Mijatovic-Rustempasic S, Casey-Moore MC, White B, et al
   Rotavirus-Specific IgA and IgG Patterns During the First 2 Years of Life in the PREVAIL Birth Cohort.
   J Infect Dis. 2026;234:e290-e301.
   PubMed         Abstract available
   
   
7. PINELL-MCNAMARA VA, Ouedraogo HS, Kafando L, Sani O, et al
   Bacterial Meningitis Epidemiology in Burkina Faso and Niger - High-Risk Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2023.
   J Infect Dis. 2026 Feb 24:jiag116. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   JAMA

8. LIPSON RA, Senerth E, Watson MA, Saini H, et al
   COVID-19 Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season.
   JAMA. 2026 Sep 2. doi: 10.1001/jama.2026.18191.
   PubMed         Abstract available
   
   
9. FRYHOFER SA, Garcia AM, Osterholm MT, Walensky RP, et al
   Respiratory Season Virus Vaccines: Restoring Confidence and Trust.
   JAMA. 2026 Sep 2. doi: 10.1001/jama.2026.18338.
   PubMed        
   
   
10. SENERTH E, Sheikholeslamian SM, Sivakumaran K, Watson MA, et al
    Influenza Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season.
    JAMA. 2026 Sep 2. doi: 10.1001/jama.2026.18126.
    PubMed         Abstract available
    
    

    
    Lancet

11. DA ASCENSAO GONCALVES MA, de Morais AF, Pascoal CA, Montefusco-Pereira CV, et al
    Gold standard vaccine policy as a global health signal.
    Lancet. 2026 Sep 4:S0140-6736(26)01698-3. doi: 10.1016/S0140-6736(26)01698.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

12. PINGALI C, Yankey D, Elam-Evans LD, Trahan A, et al
    Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:530-538.
    PubMed         Abstract available
    
    

    
    N Engl J Med

13. WORKMAN S
    Childhood Vaccine Hesitancy.
    N Engl J Med. 2026;395:933.
    PubMed        
    
    
14. O'LEARY ST, Danchin M
    Childhood Vaccine Hesitancy. Reply.
    N Engl J Med. 2026;395:934.
    PubMed        
    
    

    
    Pediatrics

15. 
    Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Technical Report.
    Pediatrics. 2026 Sep 2. doi: 10.1542/peds.2026-079046.
    PubMed         Abstract available
    
    
16. 
    Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Policy Statement.
    Pediatrics. 2026 Sep 2. doi: 10.1542/peds.2026-079045.
    PubMed         Abstract available
    
    
17. NAURECKAS LI C, Edwards KM, Kaplan SL, Marshall GS, et al
    What's Old Is New Again: Varicella.
    Pediatrics. 2026;158:e2026076519.
    PubMed         Abstract available
    
    
18. PAYNE AB, Battan-Wraith S, Reese SE, Hathaway CA, et al
    Effectiveness of RSV Prevention Strategies in US Infants: 2024-2025.
    Pediatrics. 2026 Aug 4:e2026076089. doi: 10.1542/peds.2026-076089.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

19. FREEDMAN AS, Nielsen BF, Saad-Roy CM, Grenfell BT, et al
    Economic factors promoting vaccine nationalism in the face of viral evolution.
    PLoS Comput Biol. 2026;22:e1014466.
    PubMed         Abstract available
    
    

    
    PLoS Med

20. ELIAS KM, Mitchell A, Stadler E, Schlub TE, et al
    Neutralising antibodies and protection from progression to severe COVID-19: A meta-analysis.
    PLoS Med. 2026;23:e1005230.
    PubMed         Abstract available
    
    

    
    PLoS One

21. MALANDE OO, Deogratias M, Songok JJ, Hassan S, et al
    Strengthened HPV vaccination among adolescents living with HIV, - Findings of a Pilot QI project in Kampala Metropolitan, Uganda.
    PLoS One. 2026;21:e0356686.
    PubMed         Abstract available
    
    
22. HAWKES BA, Hollister J, Porter C, Lyski ZL, et al
    Age-specific humoral immune response to SARS-CoV-2: A comparative analysis of antibody levels in children and adults after vaccination with primary series or infection.
    PLoS One. 2026;21:e0356178.
    PubMed         Abstract available
    
    
23. KIM M, Shim E
    Breakthrough infections and incomplete vaccine efficacy drive pathogen immune escape.
    PLoS One. 2026;21:e0356544.
    PubMed         Abstract available
    
    
24. OMIDIMORAD A, Kolahdooz F, Kolahdooz G, Wagg A, et al
    Human papillomavirus (HPV) and HPV vaccine awareness in Indigenous communities in Northwest Territories, Canada.
    PLoS One. 2026;21:e0357586.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

25. KARADAKIC R, Keating NL, Barnett ML
    Interpreting vaccine-associated survival differences in immune checkpoint inhibitor therapy.
    Proc Natl Acad Sci U S A. 2026;123:e2621501123.
    PubMed         Abstract available
    
    
26. NISHIDA J, Seehawer M, Rojas Jimenez E, Yan P, et al
    Breast cancer prevention by prophylactic Lalba mRNA-LNP vaccination.
    Proc Natl Acad Sci U S A. 2026;123:e2621855123.
    PubMed         Abstract available
    
    

    
    Science

27. SEMON A, Manzer HS, Keenan O, Zhou TH, et al
    Early-life colonization with Clostridioides difficile remodels the developing gut.
    Science. 2026;393:1045-1052.
    PubMed         Abstract available
    
    

    
    Vaccine

28. KORNUTA CA, Zhou G, Kane KP, Vliagoftis H, et al
    Mucosal adjuvant activity of a PAR-2-activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime-boost influenza vaccination model.
    Vaccine. 2026;92:129110.
    PubMed         Abstract available
    
    
29. ZHENG Y, Qiao B, Gao Z, Zhang X, et al
    Development of a subunit vaccine candidate (RBD-HA trimer) provides dual protection against multi-subtype avian influenza viruses and QX-type infectious bronchitis virus.
    Vaccine. 2026;92:129121.
    PubMed         Abstract available
    
    
30. MARIA DA, Martins IM, Porto GPM, Villas-Boas IM, et al
    Safety, humoral and cellular immune responses to a pre-pandemic adjuvanted influenza A (H5N8) vaccine.
    Vaccine. 2026;92:129049.
    PubMed         Abstract available
    
    
31. TRAN S, McClymont E, Blitz S, Barrett J, et al
    Self-reported reactogenicity after COVID-19 vaccination with and without influenza vaccine coadministration during pregnancy in Canada.
    Vaccine. 2026;92:129122.
    PubMed         Abstract available
    
    
32. ACHARYA KP, Phuyal S, Branda F
    Beyond anthelmintics: Can vaccines offer a sustainable path for liver fluke control?
    Vaccine. 2026;92:129075.
    PubMed        
    
    
33. COSTA NS
    Temporal validation of machine-learning models for shingles vaccine nonvaccination among U.S. adults aged 50 years and older.
    Vaccine. 2026;92:129099.
    PubMed         Abstract available
    
    
34. NIAN H, Ding T, Lee RL, Gebretsadik T, et al
    COVID-19 vaccine uptake among individuals with Down syndrome in the Unites States.
    Vaccine. 2026;92:129128.
    PubMed         Abstract available
    
    
35. MOHAMMED H, Andraweera P, Marshall HS
    A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women.
    Vaccine. 2026;91:129081.
    PubMed         Abstract available
    
    
36. ALAMI A, Lewis M, El-Chaar D, Walker M, et al
    Maternal vaccination with RSVpreF and risk of hypertensive disorders of pregnancy: a systematic review and meta-analysis.
    Vaccine. 2026;91:129070.
    PubMed         Abstract available
    
    
37. MCCONEGHY KW, Wilker EH, DeVone F, Skov B, et al
    Erratum to "Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025-2026" [Vaccine 88 (2026) 128882].
    Vaccine. 2026 Aug 29:129072. doi: 10.1016/j.vaccine.2026.129072.
    PubMed        
    
    
38. SIMUZINGILI M, Fernandez-Soberon S, Yi Z, Cossrow N, et al
    Evaluating the potential lifetime health and economic impact of PCV21, an adult-specific 21-valent pneumococcal conjugate vaccine, on invasive pneumococcal disease in adults aged >/=45 years in Spain.
    Vaccine. 2026;91:129077.
    PubMed         Abstract available
    
    
39. MUSRATI MA, Shenaisheh S, Elemraid MA
    Ethical considerations of incentive structures in vaccine acceptance research.
    Vaccine. 2026;91:129102.
    PubMed        
    
    
40. TAN L, Fang Y, Liu P, Su M, et al
    An immunoinformatics-based multi-epitope vaccine candidate confers cross-protection against two Actinobacillus pleuropneumoniae serovars.
    Vaccine. 2026;91:129104.
    PubMed         Abstract available
    
    
41. GAO SL, Yan JC, Wang J, Liu QY, et al
    A recombinant attenuated PRRSV vaccine expressing the PCV2 capsid protein confers protective immunity in pigs.
    Vaccine. 2026;91:129106.
    PubMed         Abstract available
    
    
42. ANDREWS JR, Hermans S, White RG, Garcia-Basteiro AL, et al
    Evaluating the influence of vaccine archetypes and epidemiological conditions on clinical trial metrics for tuberculosis vaccine candidates.
    Vaccine. 2026;91:129097.
    PubMed         Abstract available
    
    
43. ZHANG J, Askenase P, Crumpacker C
    A leap forward in vaccination - a molecular process of epigenetic silencing to the virus.
    Vaccine. 2026;91:129119.
    PubMed         Abstract available
    
    
44. IONESCU IG, Ouakki M, Breton O, Panicker G, et al
    Follow up immunogenicity of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccines 36 months post-vaccination among boys and girls.
    Vaccine. 2026;92:129107.
    PubMed         Abstract available
    
    
45. SHEN AK, Tupps C, Bino S, Chipoya M, et al
    Investments in seasonal influenza vaccination programs pack a punch for pandemic preparedness.
    Vaccine. 2026;92:129098.
    PubMed         Abstract available
    
    
46. DUDLEY MZ, Ali H, Villaescusa MR, Law B, et al
    Incidence, risk factors, and association with vaccination of thrombocytopenia and immune thrombocytopenia (ITP): A scoping review.
    Vaccine. 2026;92:129120.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum